中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2009年
41期
2934-2937
,共4页
雷云霞%张晓%崔阳%董光富%罗日强
雷雲霞%張曉%崔暘%董光富%囉日彊
뢰운하%장효%최양%동광부%라일강
结缔组织病%肺动脉高压
結締組織病%肺動脈高壓
결체조직병%폐동맥고압
Connective tissue disease%Pulmonary arterial hypertension
目的 了解结缔组织病相关的肺动脉高压(PAH)的发生率,评估临床特点与PAH发生的相关性、探讨早期诊断及治疗方法.方法 从1892例结缔组织病患者中筛选出伴有肺动脉高压的患者79例,对其临床实验室检查特点及治疗转归进行回顾性分析,找出并发PAH相关的危险因素,评价不同治疗、不同原发病对预后的影响.结果 结缔组织病合并的PAH的总发生率约为4.2%.其中系统性硬化症(SSc)合并肺动脉高压发生率最高,为18.18%.混合性结缔组织病(MCTD)次之12.00%,显著高于皮肌炎/多发性肌炎、系统性红斑狼疮、干燥综合征、类风湿关节炎、抗磷脂综合征等结缔组织病(P<0.01).临床伴有雷诺现象者肺动脉压力显著高于无雷诺现象者(P<0.01).高球蛋白血症、抗U1RNP(+)、ACA-IgG(+)、心包积液、肺问质病变的结缔组织病患者更易出现PAH,且与严重程度呈相关性(P<0.05).结论 结缔组织病中PAH是较为常见的并发症,其中在SSc和MCTD发生率最高.雷诺现象、抗U1RNP阳性、ACA-IgG(+)提示结缔组织病患者有更易发生PAH的可能.
目的 瞭解結締組織病相關的肺動脈高壓(PAH)的髮生率,評估臨床特點與PAH髮生的相關性、探討早期診斷及治療方法.方法 從1892例結締組織病患者中篩選齣伴有肺動脈高壓的患者79例,對其臨床實驗室檢查特點及治療轉歸進行迴顧性分析,找齣併髮PAH相關的危險因素,評價不同治療、不同原髮病對預後的影響.結果 結締組織病閤併的PAH的總髮生率約為4.2%.其中繫統性硬化癥(SSc)閤併肺動脈高壓髮生率最高,為18.18%.混閤性結締組織病(MCTD)次之12.00%,顯著高于皮肌炎/多髮性肌炎、繫統性紅斑狼瘡、榦燥綜閤徵、類風濕關節炎、抗燐脂綜閤徵等結締組織病(P<0.01).臨床伴有雷諾現象者肺動脈壓力顯著高于無雷諾現象者(P<0.01).高毬蛋白血癥、抗U1RNP(+)、ACA-IgG(+)、心包積液、肺問質病變的結締組織病患者更易齣現PAH,且與嚴重程度呈相關性(P<0.05).結論 結締組織病中PAH是較為常見的併髮癥,其中在SSc和MCTD髮生率最高.雷諾現象、抗U1RNP暘性、ACA-IgG(+)提示結締組織病患者有更易髮生PAH的可能.
목적 료해결체조직병상관적폐동맥고압(PAH)적발생솔,평고림상특점여PAH발생적상관성、탐토조기진단급치료방법.방법 종1892례결체조직병환자중사선출반유폐동맥고압적환자79례,대기림상실험실검사특점급치료전귀진행회고성분석,조출병발PAH상관적위험인소,평개불동치료、불동원발병대예후적영향.결과 결체조직병합병적PAH적총발생솔약위4.2%.기중계통성경화증(SSc)합병폐동맥고압발생솔최고,위18.18%.혼합성결체조직병(MCTD)차지12.00%,현저고우피기염/다발성기염、계통성홍반랑창、간조종합정、류풍습관절염、항린지종합정등결체조직병(P<0.01).림상반유뢰낙현상자폐동맥압력현저고우무뢰낙현상자(P<0.01).고구단백혈증、항U1RNP(+)、ACA-IgG(+)、심포적액、폐문질병변적결체조직병환자경역출현PAH,차여엄중정도정상관성(P<0.05).결론 결체조직병중PAH시교위상견적병발증,기중재SSc화MCTD발생솔최고.뢰낙현상、항U1RNP양성、ACA-IgG(+)제시결체조직병환자유경역발생PAH적가능.
Objective To understand the prevalence, investigate the correlation of clinical features, explore the early-stage diagnosis and treatment of pulmonary arterial hypertension(PAH)in patients with connective tissue disease(CTD).Methods All cases with pulmonary arterial hypertension in 1892 CTD patients were analyzed retrospectively. The risk factor of PAH was evaluated and the prognostic influence of difierent treatments and primary diseases analyzed. Results The prevalence of PAH in patients with connective tissue disease wag about 4.2%(79/1 892).In these patients, systemic sclerosis (SSc)and mixed connective tissue disease(MCTD)had the highest incidence of PAH(18.18%and 12.00%)(P<0.01).It was obviously higher than polymyositis/dermatomyositis(6.2%),systemic lupus erythematosus(4.4%),Sjogren syndrome(3.8%),rheumatoid arthritis(0.8%)and anti-phospholipid syndrome(0.5%),etc.(P<0.01).Raynaud's phenomenon was related to a higher pulmonary arterial pressure(P<0.01).There was a positive correlation(P<0.01)between the presence of Raynaud's phenomenon and pulmonary arterial pressure. Abnormal lung function was a common finding. There were associations(P<0.05)between the degree of pulmonary hypertension and IgG,anti-U1RNP antibody positive, antiphospholipid antibody positive, pericardial effusion and interstitial pneumonia. Conclusion PAH is common in connective tissue disease. SSc and MCTD have the highest prevalence of PAH. The presence of Raynaud's phenomenon anti-U1RNP antibody is positively correlated with pulmonary arterial pressure. It can predict the development of PAH. It is useful to perform ultraechocardiogrphy for an earlystage diagnosis and prognostic analysis.